About this Research Topic
The national conference on Antimicrobial Resistance, Environmental Microbiology, and Industrial Solutions (ARTEMIS 2024) hosted by the Institute of Advanced Research has been held on the 21st and 22nd of March 2024. This interdisciplinary forum aims to improve the comprehension and management of microbial interactions across various environments, addressing challenges such as antimicrobial resistance to promote a healthy and sustainable future.
Understanding the dynamic roles of microorganisms in our world is vital, making microbial research spanning Antimicrobial Resistance (AMR), Environmental Microbiology, and Industrial Solutions crucial. The escalating threat of AMR poses a global health crisis, necessitating innovative strategies to combat resistant strains. Environmental Microbiology challenges us to understand the intricate relationships between microorganisms and their environments, fostering sustainable solutions to global issues such as climate change and pollution. Industrial solutions include harnessing microorganisms for sustainable applications, from enzyme production to waste treatment. This Research Topic aims to connect these realms, fostering interdisciplinary collaboration to address challenges and drive innovation. By delving into the microbial frontiers, we seek to unravel complexities and inspire novel approaches for a healthier, more sustainable future.
This Research Topic, in collaboration with ARTEMIS 2024, covers three dynamic areas of study: Antimicrobial Resistance, Environmental Microbiology, and Industrial Solutions. We welcome original research articles, reviews, and methodological papers that explore the interconnected nature of microbial processes in health, ecosystems, and industry.
Some specific themes we're interested in including novel strategies to combat AMR, insights into microbial contributions to environmental processes, and innovative applications in industrial settings. We encourage authors to contribute to this collaborative effort, fostering interdisciplinary insights and shaping the future of microbial research and applications.
For the Antimicrobials, Resistance and Chemotherapy section we do not consider submissions that:
1. Report genomic sequence(s) that do not have a substantive biologically relevant functional part.
2. Papers that address antimicrobial resistance from an exclusively phenotypic perspective.
3. Clinical studies that do not have parts addressing molecular epidemiology of pathogens and genetic background of antimicrobial resistance.
For the Microbiotechnology section we do not consider submissions that:
1. Describe meta-omics studies since are out of scope as are medical papers.
2. Describe studies lacking a hypothesis or application, characterization studies (e.g. of enzymes, organisms), bioinformatic analyses (e.g. genome sequences) without further in vitro validation or extensive comparative analyses, chemical work that excludes a microbial component.
Understanding the dynamic roles of microorganisms in our world is vital, making microbial research spanning Antimicrobial Resistance (AMR), Environmental Microbiology, and Industrial Solutions crucial. The escalating threat of AMR poses a global health crisis, necessitating innovative strategies to combat resistant strains. Environmental Microbiology challenges us to understand the intricate relationships between microorganisms and their environments, fostering sustainable solutions to global issues such as climate change and pollution. Industrial solutions include harnessing microorganisms for sustainable applications, from enzyme production to waste treatment. This Research Topic aims to connect these realms, fostering interdisciplinary collaboration to address challenges and drive innovation. By delving into the microbial frontiers, we seek to unravel complexities and inspire novel approaches for a healthier, more sustainable future.
This Research Topic, in collaboration with ARTEMIS 2024, covers three dynamic areas of study: Antimicrobial Resistance, Environmental Microbiology, and Industrial Solutions. We welcome original research articles, reviews, and methodological papers that explore the interconnected nature of microbial processes in health, ecosystems, and industry.
Some specific themes we're interested in including novel strategies to combat AMR, insights into microbial contributions to environmental processes, and innovative applications in industrial settings. We encourage authors to contribute to this collaborative effort, fostering interdisciplinary insights and shaping the future of microbial research and applications.
For the Antimicrobials, Resistance and Chemotherapy section we do not consider submissions that:
1. Report genomic sequence(s) that do not have a substantive biologically relevant functional part.
2. Papers that address antimicrobial resistance from an exclusively phenotypic perspective.
3. Clinical studies that do not have parts addressing molecular epidemiology of pathogens and genetic background of antimicrobial resistance.
For the Microbiotechnology section we do not consider submissions that:
1. Describe meta-omics studies since are out of scope as are medical papers.
2. Describe studies lacking a hypothesis or application, characterization studies (e.g. of enzymes, organisms), bioinformatic analyses (e.g. genome sequences) without further in vitro validation or extensive comparative analyses, chemical work that excludes a microbial component.
Keywords: antimicrobial resistance, drug resistance, microbial ecology, drug discovery, quorum sensing, medical microbiology, bioinformatics
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
